Anti-Obesity Drugs Market 2027 by Drug Class, Medication, Drug Type and Geography | The Insight Partners

Anti-Obesity Drugs Market to 2027 - Global Analysis and Forecasts By Drug Class ( Peripherally Acting Anti-obesity Drugs, Centrally Acting Anti-obesity Drugs ); Medication ( Monotherapies, Polytherapies ); Drug Type ( Prescription Drugs, OTC Drugs ), and Geography

Report Code: TIPRE00006850 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Pharmacological agents which are used to reduce the body weight by losing the amount of cholesterol in body are called as Anti-obesity drugs. Anti-Obesity drugs alter the fundamental functions of human body by altering the appetite or by consuming the calories.

MARKET DYNAMICS


The Anti-Obesity Drugs market is anticipated to grow in the forecast period owing to driving factors such as adoption of sedentary lifestyle, increasing prevalence of obesity, introduction of novel anti-obesity drugs, chronic nature of disease, and increasing aging population.

MARKET SCOPE

The "Global Anti-Obesity Drugs Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anti-Obesity Drugs market with detailed market segmentation by drug class, medication, drug type, and geography. The global Anti-Obesity Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anti-Obesity Drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Anti-Obesity Drugs market is segmented on the basis of drug class, medication, and drug type. Based on drug class, the market is segmented into Peripherally Acting Anti-obesity Drugs, and Centrally Acting Anti-obesity Drugs. Based on medication, the market is segmented into Monotherapies and Polytherapies. Based on drug type, the market is segmented into Prescription Drugs and OTC Drugs.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Anti-Obesity Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anti-Obesity Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Anti-Obesity Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anti-Obesity Drugs market in these regions.

MARKET PLAYERS


The reports cover key developments in the Anti-Obesity Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Anti-Obesity Drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Anti-Obesity Drugs market in the global market. Below mentioned is the list of few companies engaged in the Anti-Obesity Drugs market.

The report also includes the profiles of key Anti-Obesity Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Arena Pharmaceuticals, Inc.
  •  F. Hoffmann-La Roche Ltd
  •  GlaxoSmithKline plc
  •  Alizyme plc
  •  Boehringer Ingelheim GmbH
  •  Novo Nordisk A/S
  •  Pfizer Inc
  •  Shionogi Inc.
  •  Merck and Co., Inc.
  •  Norgine B.V.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Table of Content

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-Obesity Drugs Market - By Drug Class
1.3.2 Anti-Obesity Drugs Market - By Medication
1.3.3 Anti-Obesity Drugs Market - By Drug Type
1.3.4 Anti-Obesity Drugs Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. ANTI-OBESITY DRUGS MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTI-OBESITY DRUGS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTI-OBESITY DRUGS MARKET - GLOBAL MARKET ANALYSIS

6.1. ANTI-OBESITY DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTI-OBESITY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTI-OBESITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS

7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. PERIPHERALLY ACTING ANTI-OBESITY DRUGS
7.3.1. Overview
7.3.2. Peripherally Acting Anti-obesity Drugs Market Forecast and Analysis
7.4. CENTRALLY ACTING ANTI-OBESITY DRUGS
7.4.1. Overview
7.4.2. Centrally Acting Anti-obesity Drugs Market Forecast and Analysis

8. ANTI-OBESITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - MEDICATION

8.1. OVERVIEW
8.2. MEDICATION MARKET FORECASTS AND ANALYSIS
8.3. MONOTHERAPIES
8.3.1. Overview
8.3.2. Monotherapies Market Forecast and Analysis
8.4. POLYTHERAPIES
8.4.1. Overview
8.4.2. Polytherapies Market Forecast and Analysis

9. ANTI-OBESITY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE

9.1. OVERVIEW
9.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
9.3. PRESCRIPTION DRUGS
9.3.1. Overview
9.3.2. Prescription Drugs Market Forecast and Analysis
9.4. OTC DRUGS
9.4.1. Overview
9.4.2. OTC Drugs Market Forecast and Analysis

10. ANTI-OBESITY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Anti-Obesity Drugs Market Overview
10.1.2 North America Anti-Obesity Drugs Market Forecasts and Analysis
10.1.3 North America Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Class
10.1.4 North America Anti-Obesity Drugs Market Forecasts and Analysis - By Medication
10.1.5 North America Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Type
10.1.6 North America Anti-Obesity Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-Obesity Drugs Market
10.1.6.1.1 United States Anti-Obesity Drugs Market by Drug Class
10.1.6.1.2 United States Anti-Obesity Drugs Market by Medication
10.1.6.1.3 United States Anti-Obesity Drugs Market by Drug Type
10.1.6.2 Canada Anti-Obesity Drugs Market
10.1.6.2.1 Canada Anti-Obesity Drugs Market by Drug Class
10.1.6.2.2 Canada Anti-Obesity Drugs Market by Medication
10.1.6.2.3 Canada Anti-Obesity Drugs Market by Drug Type
10.1.6.3 Mexico Anti-Obesity Drugs Market
10.1.6.3.1 Mexico Anti-Obesity Drugs Market by Drug Class
10.1.6.3.2 Mexico Anti-Obesity Drugs Market by Medication
10.1.6.3.3 Mexico Anti-Obesity Drugs Market by Drug Type
10.2. EUROPE
10.2.1 Europe Anti-Obesity Drugs Market Overview
10.2.2 Europe Anti-Obesity Drugs Market Forecasts and Analysis
10.2.3 Europe Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Anti-Obesity Drugs Market Forecasts and Analysis - By Medication
10.2.5 Europe Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Type
10.2.6 Europe Anti-Obesity Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-Obesity Drugs Market
10.2.6.1.1 Germany Anti-Obesity Drugs Market by Drug Class
10.2.6.1.2 Germany Anti-Obesity Drugs Market by Medication
10.2.6.1.3 Germany Anti-Obesity Drugs Market by Drug Type
10.2.6.2 France Anti-Obesity Drugs Market
10.2.6.2.1 France Anti-Obesity Drugs Market by Drug Class
10.2.6.2.2 France Anti-Obesity Drugs Market by Medication
10.2.6.2.3 France Anti-Obesity Drugs Market by Drug Type
10.2.6.3 Italy Anti-Obesity Drugs Market
10.2.6.3.1 Italy Anti-Obesity Drugs Market by Drug Class
10.2.6.3.2 Italy Anti-Obesity Drugs Market by Medication
10.2.6.3.3 Italy Anti-Obesity Drugs Market by Drug Type
10.2.6.4 Spain Anti-Obesity Drugs Market
10.2.6.4.1 Spain Anti-Obesity Drugs Market by Drug Class
10.2.6.4.2 Spain Anti-Obesity Drugs Market by Medication
10.2.6.4.3 Spain Anti-Obesity Drugs Market by Drug Type
10.2.6.5 United Kingdom Anti-Obesity Drugs Market
10.2.6.5.1 United Kingdom Anti-Obesity Drugs Market by Drug Class
10.2.6.5.2 United Kingdom Anti-Obesity Drugs Market by Medication
10.2.6.5.3 United Kingdom Anti-Obesity Drugs Market by Drug Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-Obesity Drugs Market Overview
10.3.2 Asia-Pacific Anti-Obesity Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Anti-Obesity Drugs Market Forecasts and Analysis - By Medication
10.3.5 Asia-Pacific Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Type
10.3.6 Asia-Pacific Anti-Obesity Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-Obesity Drugs Market
10.3.6.1.1 Australia Anti-Obesity Drugs Market by Drug Class
10.3.6.1.2 Australia Anti-Obesity Drugs Market by Medication
10.3.6.1.3 Australia Anti-Obesity Drugs Market by Drug Type
10.3.6.2 China Anti-Obesity Drugs Market
10.3.6.2.1 China Anti-Obesity Drugs Market by Drug Class
10.3.6.2.2 China Anti-Obesity Drugs Market by Medication
10.3.6.2.3 China Anti-Obesity Drugs Market by Drug Type
10.3.6.3 India Anti-Obesity Drugs Market
10.3.6.3.1 India Anti-Obesity Drugs Market by Drug Class
10.3.6.3.2 India Anti-Obesity Drugs Market by Medication
10.3.6.3.3 India Anti-Obesity Drugs Market by Drug Type
10.3.6.4 Japan Anti-Obesity Drugs Market
10.3.6.4.1 Japan Anti-Obesity Drugs Market by Drug Class
10.3.6.4.2 Japan Anti-Obesity Drugs Market by Medication
10.3.6.4.3 Japan Anti-Obesity Drugs Market by Drug Type
10.3.6.5 South Korea Anti-Obesity Drugs Market
10.3.6.5.1 South Korea Anti-Obesity Drugs Market by Drug Class
10.3.6.5.2 South Korea Anti-Obesity Drugs Market by Medication
10.3.6.5.3 South Korea Anti-Obesity Drugs Market by Drug Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-Obesity Drugs Market Overview
10.4.2 Middle East and Africa Anti-Obesity Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Anti-Obesity Drugs Market Forecasts and Analysis - By Medication
10.4.5 Middle East and Africa Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Type
10.4.6 Middle East and Africa Anti-Obesity Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-Obesity Drugs Market
10.4.6.1.1 South Africa Anti-Obesity Drugs Market by Drug Class
10.4.6.1.2 South Africa Anti-Obesity Drugs Market by Medication
10.4.6.1.3 South Africa Anti-Obesity Drugs Market by Drug Type
10.4.6.2 Saudi Arabia Anti-Obesity Drugs Market
10.4.6.2.1 Saudi Arabia Anti-Obesity Drugs Market by Drug Class
10.4.6.2.2 Saudi Arabia Anti-Obesity Drugs Market by Medication
10.4.6.2.3 Saudi Arabia Anti-Obesity Drugs Market by Drug Type
10.4.6.3 U.A.E Anti-Obesity Drugs Market
10.4.6.3.1 U.A.E Anti-Obesity Drugs Market by Drug Class
10.4.6.3.2 U.A.E Anti-Obesity Drugs Market by Medication
10.4.6.3.3 U.A.E Anti-Obesity Drugs Market by Drug Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-Obesity Drugs Market Overview
10.5.2 South and Central America Anti-Obesity Drugs Market Forecasts and Analysis
10.5.3 South and Central America Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Anti-Obesity Drugs Market Forecasts and Analysis - By Medication
10.5.5 South and Central America Anti-Obesity Drugs Market Forecasts and Analysis - By Drug Type
10.5.6 South and Central America Anti-Obesity Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-Obesity Drugs Market
10.5.6.1.1 Brazil Anti-Obesity Drugs Market by Drug Class
10.5.6.1.2 Brazil Anti-Obesity Drugs Market by Medication
10.5.6.1.3 Brazil Anti-Obesity Drugs Market by Drug Type
10.5.6.2 Argentina Anti-Obesity Drugs Market
10.5.6.2.1 Argentina Anti-Obesity Drugs Market by Drug Class
10.5.6.2.2 Argentina Anti-Obesity Drugs Market by Medication
10.5.6.2.3 Argentina Anti-Obesity Drugs Market by Drug Type

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ANTI-OBESITY DRUGS MARKET, KEY COMPANY PROFILES

12.1. ARENA PHARMACEUTICALS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ALIZYME PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM GMBH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVO NORDISK A/S
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SHIONOGI INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MERCK AND CO., INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NORGINE B.V.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Arena Pharmaceuticals, Inc.
2. F. Hoffmann-La Roche Ltd
3. GlaxoSmithKline plc
4. Alizyme plc
5. Boehringer Ingelheim GmbH
6. Novo Nordisk A/S
7. Pfizer Inc
8. Shionogi Inc.
9. Merck and Co., Inc.
10. Norgine B.V.